Clinical Trials Directory

Trials / Unknown

UnknownNCT02680769

Effect of Magnesium Supplementation in COPD

Daily Supplementation of Magnesium Citrate in Moderate-severe Chronic Obstructive Pulmonary Disease: a Randomized, Controlled, Double-blind Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
76 (estimated)
Sponsor
University of Padova · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Magnesium (Mg) is involved in several pathways that could be affected in chronic obstructive pulmonary diseases (COPDs), namely in the contractility and excitability of neuro-muscolar endothelial cells and low-grade inflammation, a typical state of COPD. In this sense, several randomized controlled trials (RCTs) confirmed a positive role of Mg in asthma since long-period oral supplementation of Mg leads to a clinical and spirometric improvement. Subjects with COPD seem to have a reduced bioavailability of Mg probably due to the use of drugs that may increase Mg losses (e.g. beta-agonists and cortisones), to a reduced dietary Mg intake, and heavy smoking. A recent study showed that the administration of endovenous or aerosol Mg sulphate with beta-agonists acutely improve maximum expiratory flow during COPD relapses as well as the prolonged treatment with endovenous sulphate Mg led to a reduction in pulmonary hyperinflation and increase in muscles involved in respiration, with a consequent clinical and instrumental improvement. These evidences suggest that a chronic supplementation with Mg could improve COPD in clinical and instrumental parameters, but, at the best of our knowledge, no study was available in this sense.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT300 mg of citrate MgThis group will take an oral supplementation of 300 mg of citrate magnesium
OTHERPlaceboThis group will take a placebo

Timeline

Start date
2016-03-01
Primary completion
2018-03-01
Completion
2019-03-01
First posted
2016-02-12
Last updated
2016-06-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02680769. Inclusion in this directory is not an endorsement.